Nutex Health Inc. · NASDAQ:NUTX
Nutex Health — Investor Presentation (September 2023)
21 slides from Nutex Health's investor presentation, Sep 15, 2023
Slide 1: Strictly Private and Confidential
STRICTLY PRIVATE AND CONFIDENTIAL STRICTLY PRIVATE AND CONFIDENTIAL
Slide 2: Disclaimer
Disclaimer General The information contained in this Investor Presentation (“Presentation”) has been prepared by Nutex Health Inc. (“NUTX” or the “Company”) for investors, solely for informational purposes. The Presentation has been prepared to assist prospective investors in making their own evalua
Slide 3: Forward looking statements
Forward looking statements Certain statements and information included in this Presentation constitute "forward-looking statements" within the meaning of the Private Securities Litigation Act of 1995. When used in this Presentation, the words or phrases “will”, "will likely result," "expected to," "
Slide 4: Agenda
Agenda 1 Business Overview 2 Appendix CONFIDENTIAL 4
Slide 5: Management team with deep experience in healthcare
Management team with deep experience in healthcare Thomas T. Vo, M.D., MBA Warren Hosseinion, M.D. Jon Bates, MBA, CPA Josh DeTillio Chief Executive Officer President Chief Financial Officer Chief Operating Officer Michael Chang, M.D. Lawrence Schimmel, M.D. Elisa Luqman, J.D., MBA Pamela Montgomery
Slide 6: Our mission, vision, and values
Our mission, vision, and values Our Mission To make exceptional concierge-level health care more accessible to all communities, with a practice centered on patient experience and satisfaction Our Vision To be leaders in individualized patient care and innovators in the future of healthcare Our Value
Slide 7: Nutex at-a-glance
Nutex at-a-glance Owns and operates a comprehensive and integrated care Company Highlights delivery platform comprised of: Hospital Division – Develops and operates a network of micro-hospitals, specialty hospitals, and hospital outpatient departments – A micro-hospital is a small hospital inclu
Slide 8: Overview of Nutex's hospital division
Overview of Nutex’s hospital division Nutex’s Innovative Micro-Hospitals Meet their served Communities Demand for Higher Acuity Care Address Challenges of Traditional Care Access Points Network of strategically located, state-of-the-art micro-hospitals across the U.S. which service ER visits at eq
Slide 9: Nutex's micro-hospitals treat over 90% of ER acuities at a fraction of the wait time
Nutex’s micro-hospitals treat over 90% of ER acuities at a fraction of the wait time Nutex’s facilities require lower staffing and capital obligations while delivering improved quality of care, with an average patient wait time of 15 – 30 minutes U.S. National Average ER Acuity Levels 90% of ER acui
Slide 10: Turn-key de novo strategy delivering compelling and scalable facility economics
Turn-key de novo strategy delivering compelling and scalable facility economics De Novo Facility Profile De Novo Rollout Timeline Provide emergency, inpatient care, outpatient imaging, outpatient Task Timing labs, minor procedures, etc. Services / Staffing ER Physician, RNs, Radiology Technologi
Slide 11: Our focus areas represent a massive market opportunity
Our focus areas represent a massive market opportunity Population Health Management Division I) Clinigence – cloud-based SaaS and data analytics enable providers to optimize clinical Population Health outcomes and financial performance II) Procare – an MSO that provides healthcare administration and
Slide 12: How we got here
How we got here Developing a Thesis Building Nutex Pre-2008: Year 2015 2016 - 2018 2019-2020 2022 Dr. Vo develops patient- # of centric philosophies for 1 5 17 21 Facilities emergent medicine inspired by 20+ years as ER physician # of States1 1 1 8 9 2008-2011: Milestones Opened first micro- Conti
Slide 13: Overview of Nutex's population health management division
Overview of Nutex’s population health management division Proprietary, cloud-based technology system and value-based network... …to deliver fully integrated population health management Established in April 2022 upon the completion of the merger with Clinigence to form the basis of a fully integra
Slide 14: Our vision is to create an integrated, risk-bearing delivery model
Our vision is to create an integrated, risk-bearing delivery model Pioneering platform which combines a national network of patient-centric micro-hospitals with wraparound technology- Network of micro- Risk-bearing enabled primary care hospitals provider capabilities networks Proven track record
Slide 15: Existing Models
Nutex’s integrated model aligns incentives to deliver superior outcomes versus comparable elements of existing care models Providers Facility Based Care Population Health Capabilities Nutex IPA Nutex micro-hospitals Nutex proprietary cloud-based healthcare technology platform Nutex Health Me
Slide 16: Nutex has a differentiated model
Nutex has a differentiated model Existing care models Nutex’s approach Traditional hospital Traditional facility- Next-gen clinic-based ER / micro-hospitals / based care primary care urgent care Acute primary care / Facility-based care setting Standalone, tech- Micro-hospitals with Care delivery mod
Slide 17: Selected External Growth Opportunities
Selected External Growth Opportunities Core Nutex Opportunities Emerging Nutex and Micro-Hospital Opportunities IPA Development Joint Ventures Acquire or start IPAs Develop and operate facilities on behalf of health Increase capitation and full-risk contracting systems Facility Development Dig
Slide 18: Nutex strategic response to the No Surprises Act (NSA)
Nutex strategic response to the No Surprises Act (NSA) The No Surprises Act (“NSA”) is a federal law that took effect January 1, 2022, to protect consumers from most instances of “surprise” balance billing Our Strategic Response Actions: Nutex Health prides itself as a leader in billing transpar
Slide 19: Financial Overview
Financial Overview Historical Financials - Annual Commentary ($ in millions) FY2022 Hospital Division Revenue of $199mm Revenue FY2022 Population Health Division revenue of $21mm $332 Adjusted EBITDA $34mm cash and equivalents as of 12/31/2022 Several initiatives underway to power a strong g
Slide 20: Financial Overview
Financial Overview Historical Financials - Quarterly Commentary Net revenue of $58.9 million for 2nd Quarter 2023. Net cash from operating activities of $1.1 million. Adjusted EBITDA of $4.0 million. As of June 30, 2023, the Company had total assets of $436.2 million, including cash and cash
Slide 21: Investment Highlights
Investment Highlights Well-positioned for major trends in a large and attractive market (high-quality, patient-centric hospital 1 inpatient care and value-based outpatient care) Deep value proposition to the healthcare ecosystem from our comprehensive portfolio of coordinated 2 assets, delivering hi
Nutex Health — Investor Presentation (September 2023) on 6ix